CorVel Announces Effectiveness of Three-For-One Forward Stock Split 
HWH International Inc. and Sharing Services Global Corporation see opportunity in Robotics
BETHESDA, MD, Dec. 20, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) and its partner Sharing Services Global...
Light-it Group Launches Enlighten Ventures: A Micro-VC Initiative to Propel Healthtech Innovation
Javier Lempert (CTO & Founder), Alan Brande (CEO & Founder) and Martin Oppenheimer (COO & Founder) at Light-it’s HQ. AVENTURA,...
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in...
Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ORANGE, Calif. , Dec. 20, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present...
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
FOSTER CITY, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical...
Commure Acquires Memora Health, a Digital Care Navigation Platform, to Enhance Intelligent Care Navigation
MOUNTAIN VIEW, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, announced today the acquisition of...
RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric...
Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH
In the pre-specified per-protocol population, belapectin showed a statistically significant reduction (p-value < 0.05) in development of esophageal varices in...
Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets
HAMILTON, BERMUDA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Trading to continue under ticker symbol “CYTOF”No reverse stock split planned Altamira...
Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading...
NervGen Announces “At-The-Market” Equity Program
Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a...
Prytime Medical Announces Key Prolonged REBOA Advancements to Treat Maternal Hemorrhage
BOERNE, Texas, Dec. 20, 2024 /PRNewswire/ -- Prytime Medical, The REBOA Company™, is proud to announce significant strides made in...
ZuriMED Secures FDA Clearance for the FiberLocker(R) System
BOSTON, MA / ZURICH, SWITZERLAND / ACCESSWIRE / December 20, 2024 / The Swiss MedTech startup ZuriMED Technologies AG is...
Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the...
FendX Announces RSU Grant
Oakville, Ontario--(Newsfile Corp. - December 19, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif., Dec. 19, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company")...
Array Behavioral Care Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
HITRUST e1 Certification validates Array Behavioral Care is committed to foundational cybersecurity controls and information risk management. MOUNT LAUREL, N.J.,...
Astraveus Secures €7.1M Non-dilutive Funding from the French State
PARIS, Dec. 19, 2024 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell Factory company aiming for maximized...
Bryan Johnson, Dave Asprey, Dr Michael Ashenden United With Olympians and Anti-Doping Experts to Forge the Future of Human Enhancement
Historic Second Conference on Human Enhancement brought together world leaders in sports and science. Leading scientists ratified Declaration on Human...